Literature DB >> 19794146

IFN{gamma} regulates retinal pigment epithelial fluid transport.

Rong Li1, Arvydas Maminishkis, Tina Banzon, Qin Wan, Stephen Jalickee, Shan Chen, Sheldon S Miller.   

Abstract

The present experiments show that IFNgamma receptors are mainly localized to the basolateral membrane of human retinal pigment epithelium (RPE). Activation of these receptors in primary cultures of human fetal RPE inhibited cell proliferation and migration, decreased RPE mitochondrial membrane potential, altered transepithelial potential and resistance, and significantly increased transepithelial fluid absorption. These effects are mediated through JAK-STAT and p38 MAPK signaling pathways. Second messenger signaling through cAMP-PKA pathway- and interferon regulatory factor-1-dependent production of nitric oxide/cGMP stimulated the CFTR at the basolateral membrane and increased transepithelial fluid absorption. In vivo experiments using a rat model of retinal reattachment showed that IFNgamma applied to the anterior surface of the eye can remove extra fluid deposited in the extracellular or subretinal space between the retinal photoreceptors and RPE. Removal of this extra fluid was blocked by a combination of PKA and JAK-STAT pathway inhibitors injected into the subretinal space. These results demonstrate a protective role for IFNgamma in regulating retinal hydration across the outer blood-retinal barrier in inflammatory disease processes and provide the basis for possible therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19794146      PMCID: PMC2793058          DOI: 10.1152/ajpcell.00255.2009

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  75 in total

Review 1.  Regulation of JAK-STAT signalling in the immune system.

Authors:  Ke Shuai; Bin Liu
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

Review 2.  Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond.

Authors:  Steven B Koevary
Journal:  Curr Drug Metab       Date:  2003-06       Impact factor: 3.731

3.  The P2Y(2) receptor agonist INS37217 stimulates RPE fluid transport in vitro and retinal reattachment in rat.

Authors:  Arvydas Maminishkis; Stephen Jalickee; Sasha A Blaug; Jodi Rymer; Benjamin R Yerxa; Ward M Peterson; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-11       Impact factor: 4.799

4.  Retinal pigment epithelial function: a role for CFTR?

Authors:  Sasha Blaug; Richard Quinn; Judy Quong; Stephen Jalickee; Sheldon S Miller
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

Review 5.  Ocular neovascularisation and excessive vascular permeability.

Authors:  Peter A Campochiaro
Journal:  Expert Opin Biol Ther       Date:  2004-09       Impact factor: 4.388

Review 6.  The p38 mitogen-activated protein kinase pathway and its role in interferon signaling.

Authors:  Leonidas C Platanias
Journal:  Pharmacol Ther       Date:  2003-05       Impact factor: 12.310

Review 7.  Anti-inflammatory properties of pro-inflammatory interferon-gamma.

Authors:  Heiko Mühl; Josef Pfeilschifter
Journal:  Int Immunopharmacol       Date:  2003-09       Impact factor: 4.932

8.  Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases.

Authors:  J J Hooks; C C Chan; B Detrick
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-09       Impact factor: 4.799

9.  Benzyl alcohol-induced destabilization of interferon-gamma: a study by hydrogen-deuterium isotope exchange.

Authors:  Scott A Tobler; Bryan W Holmes; Mary E M Cromwell; Erik J Fernandez
Journal:  J Pharm Sci       Date:  2004-06       Impact factor: 3.534

10.  Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy.

Authors:  Chatchai Muanprasat; N D Sonawane; Danieli Salinas; Alessandro Taddei; Luis J V Galietta; A S Verkman
Journal:  J Gen Physiol       Date:  2004-08       Impact factor: 4.086

View more
  22 in total

1.  MicroRNA-204/211 alters epithelial physiology.

Authors:  Fei E Wang; Connie Zhang; Arvydas Maminishkis; Lijin Dong; Connie Zhi; Rong Li; Jing Zhao; Vladimir Majerciak; Arti B Gaur; Shan Chen; Sheldon S Miller
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

2.  Stimulation of aquaporin-mediated fluid transport by cyclic GMP in human retinal pigment epithelium in vitro.

Authors:  Nicholas W Baetz; W Daniel Stamer; Andrea J Yool
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

Review 3.  Nanofiber Scaffold-Based Tissue-Engineered Retinal Pigment Epithelium to Treat Degenerative Eye Diseases.

Authors:  Nathan A Hotaling; Vladimir Khristov; Qin Wan; Ruchi Sharma; Balendu Shekhar Jha; Mostafa Lotfi; Arvydas Maminishkis; Carl G Simon; Kapil Bharti
Journal:  J Ocul Pharmacol Ther       Date:  2016-04-25       Impact factor: 2.671

Review 4.  Cultured primary human fetal retinal pigment epithelium (hfRPE) as a model for evaluating RPE metabolism.

Authors:  Jeffrey Adijanto; Nancy J Philp
Journal:  Exp Eye Res       Date:  2014-01-28       Impact factor: 3.467

5.  Potentially pathogenic immune cells and networks in apparently healthy lacrimal glands.

Authors:  Austin K Mircheff; Yanru Wang; Chuanqing Ding; Dwight W Warren; Joel E Schechter
Journal:  Ocul Surf       Date:  2014-11-06       Impact factor: 5.033

6.  The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells.

Authors:  Kapil Bharti; Sheldon S Miller; Heinz Arnheiter
Journal:  Pigment Cell Melanoma Res       Date:  2010-10-07       Impact factor: 4.693

Review 7.  Next-generation therapeutic solutions for age-related macular degeneration.

Authors:  Khrishen Cunnusamy; Rafael Ufret-Vincenty; Shusheng Wang
Journal:  Pharm Pat Anal       Date:  2012-05

8.  Pro-angiogenic effect of IFNgamma is dependent on the PI3K/mTOR/translational pathway in human retinal pigmented epithelial cells.

Authors:  Baoying Liu; Lisa Faia; Mengjun Hu; Robert B Nussenblatt
Journal:  Mol Vis       Date:  2010-02-10       Impact factor: 2.367

9.  Developing cellular therapies for retinal degenerative diseases.

Authors:  Kapil Bharti; Mahendra Rao; Sara Chandros Hull; David Stroncek; Brian P Brooks; Ellen Feigal; Jan C van Meurs; Christene A Huang; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-26       Impact factor: 4.799

10.  The retinal pigment epithelium utilizes fatty acids for ketogenesis.

Authors:  Jeffrey Adijanto; Jianhai Du; Cynthia Moffat; Erin L Seifert; James B Hurle; Nancy J Philp
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.